US Broker Ratings

Concentra Group Holdings Parent (CON) Stock Analysis: A 22% Upside Potential with Robust Growth Metrics

Concentra Group Holdings Parent, Inc. (NASDAQ: CON), a significant player in the U.S. healthcare sector, particularly in the medical care facilities industry, presents a compelling opportunity for investors seeking growth..

PROCEPT BioRobotics (PRCT) Stock Analysis: Unpacking the 85% Upside Potential

For investors keen on the healthcare sector, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) offers a compelling opportunity. Specializing in transformative medical devices, this surgical robotics company is focused on revolutionizing urology..

GoodRx Holdings, Inc. (GDRX) Investor Outlook: Exploring a Potential 100% Upside

For investors seeking opportunities in the healthcare sector, GoodRx Holdings, Inc. (NASDAQ: GDRX) presents an intriguing case with its significant potential upside. The company, with a market capitalization of $788.71..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring a 376% Upside in Biotechnology

Janux Therapeutics, Inc. (NASDAQ: JANX), a burgeoning name in the biotechnology sector, is capturing investor attention with its pioneering approach to cancer treatment through immunotherapy. With a market capitalization of..

CG Oncology, Inc. (CGON) Stock Analysis: Unveiling a Potential 36.95% Upside in the Biotech Sector

CG Oncology, Inc. (NASDAQ: CGON), a dynamic player in the healthcare sector, is capturing investor attention with its promising pipeline of bladder cancer therapies and an impressive potential upside of..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a 31.39% Potential Upside for Savvy Investors

Bausch Health Companies Inc. (NYSE: BHC), a key player in the healthcare sector, has piqued investor interest with its diverse portfolio and substantial growth potential. Headquartered in Laval, Canada, Bausch..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Growth in the Dental Market with a 15% Revenue Surge

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector, is steadily carving out its niche in the medical instruments and supplies industry. With a market capitalization of..

Ardent Health, Inc. (ARDT) Stock Analysis: Unveiling a 34.57% Upside Potential in Healthcare

Ardent Health, Inc. (ARDT), a prominent player in the healthcare sector specializing in medical care facilities, is capturing investor attention with its promising growth potential. Based in Brentwood, Tennessee, and..

Schrödinger, Inc. (SDGR) Stock Analysis: Unveiling a 126.78% Potential Upside in the Healthcare Sector

For investors with an eye on the healthcare sector, Schrödinger, Inc. (NASDAQ: SDGR) presents a compelling opportunity. This New York-based company, known for its innovative use of physics-based computational platforms,..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: A 39% Upside Potential Sparks Investor Interest

Travere Therapeutics, Inc. (NASDAQ: TVTX), a biopharmaceutical company headquartered in San Diego, California, is focused on developing therapies for rare kidney and metabolic diseases. With a market capitalization of $2.75..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: Exploring a 51% Upside Potential

For investors seeking opportunities within the biotechnology sector, Apellis Pharmaceuticals, Inc. (APLS) presents a compelling case. With a market capitalization of $2.84 billion, this Massachusetts-based company is carving out its..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Potential 97.71% Upside for Patient Investors

Ascentage Pharma Group International (AAPG), a clinical-stage biotechnology company based in China, is making waves in the healthcare sector with its innovative pipeline targeting cancers and chronic diseases. With a..

Select Medical Holdings Corp (SEM) Stock Analysis: Exploring a 19.35% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM) operates at the intersection of healthcare innovation and patient care, providing a broad spectrum of services across critical illness recovery hospitals, rehabilitation hospitals, and..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: A 28.73% Upside Potential Amidst Strong Revenue Growth

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a prominent player in the biotechnology sector, is drawing significant attention from investors with a market cap of $1.77 billion. Specializing in the discovery and..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Uncertain Waters with Limited Analyst Insight

BGM Group Ltd. (BGM), a healthcare company entrenched in China’s dynamic pharmaceutical landscape, is catching the eye of investors with its unique product offerings. However, the company’s financial metrics and..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Uncovering an 87% Potential Upside

Alphatec Holdings, Inc. (NASDAQ: ATEC) is making waves in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $1.95 billion, Alphatec is a prominent player..

Galapagos NV (GLPG) Stock Analysis: Navigating a Challenging Biotech Landscape with Innovative CAR-T Therapies

Galapagos NV (NASDAQ: GLPG), a Belgium-based biotechnology firm, is making strides in the healthcare sector by focusing on cutting-edge therapies in oncology and immunology. The company has a significant market..

CONMED Corporation (CNMD) Stock Analysis: Navigating Growth in Medical Devices with a 4.45% Upside

CONMED Corporation (NASDAQ: CNMD), a key player in the healthcare sector, specializes in the medical device industry. As a U.S.-based company with a market capitalization of $1.41 billion, CONMED is..

PACS Group, Inc. (PACS)

⚠️ No article content returned.

..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Evaluating a 26% Potential Upside with Robust Revenue Growth

Alignment Healthcare, Inc. (NASDAQ: ALHC) is making waves in the healthcare sector with its innovative approach to senior care through Medicare Advantage plans. Established in 2013 and headquartered in Orange,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds